News
Tempus AI reassured investors that its major pharma contracts remain strong despite funding and tariff pressures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback